MeCP2 co-ordinates liver lipid metabolism with the NCoR1/HDAC3 corepressor complex

Rett syndrome (RTT; OMIM 312750), a progressive neurological disorder, is caused by mutations in methyl-CpG-binding protein 2 (MECP2; OMIM 300005), a ubiquitously expressed factor. A genetic suppressor screen designed to identify therapeutic targets surprisingly revealed that downregulation of the cholesterol biosynthesis pathway improves neurological phenotypes in Mecp2 mutant mice. Here, we show that MeCP2 plays a direct role in regulating lipid metabolism. Mecp2 deletion in mice results in a host of severe metabolic defects caused by lipid accumulation, including insulin resistance, fatty liver, perturbed energy utilization, and adipose inflammation by macrophage infiltration. We show that MeCP2 regulates lipid homeostasis by anchoring the repressor complex containing NCoR1 and HDAC3 to its lipogenesis targets in hepatocytes. Consistently, we find that liver targeted deletion of Mecp2 causes fatty liver disease and dyslipidemia similar to HDAC3 liver-specific deletion. These findings position MeCP2 as a novel component in metabolic homeostasis. Rett syndrome patients also show signs of peripheral dyslipidemia; thus, together these data suggest that RTT should be classified as a neurological disorder with systemic metabolic components. We previously showed that treatment of Mecp2 mice with statin drugs alleviated motor symptoms and improved health and longevity. Lipid metabolism is a highly treatable target; therefore, our results shed light on new metabolic pathways for tr...
Source: Human Molecular Genetics - Category: Genetics & Stem Cells Authors: Tags: ARTICLES Source Type: research

Related Links:

FATTY liver disease is an umbrella term for a range of conditions characterised by abnormal levels of fat in the liver. Although the condition is often marked by an absence of symptoms, there are certain signs to look out for when you go to the toilet.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
FATTY liver disease is caused by a build-up of fat in the liver, and it's linked to obesity and a poor diet. Here are three foods to avoid to reverse the disease.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Contributors : Ying Yan ; Zhoumin Niu ; Chao Sun ; Peng Li ; Siyi Shen ; Shengnan Liu ; Yuying Li ; Zhong-Ze Fang ; Lin Zhao ; Changtao Jiang ; Jingjing Jiang ; Hao YingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusA greater understanding of the glucose homeostasis mediated by glucagon-like peptide-1 (GLP-1) will facilitate the development of novel glucose-lowering treatments. Here we show that improved glucose metabolism in hypothyroid mice after treatment of T3, the active form of thyroid hormone (TH), is accompanied with increased GLP-1 production and insulin secretion. Treatment...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Mus musculus Source Type: research
AbstractReflecting the growing interest in early diagnosis of non-alcoholic fatty liver disease in recent years, the development of noninvasive and reliable fat quantification methods is needed. Dual-energy computed tomography (DE-CT) is a quantitative diagnostic imaging method that estimates the composition of the imaging target using a material decomposition technique based on the X-ray absorption characteristics peculiar to substances from DE-CT scanning using X-rays generated with different energies (tube voltage). In this review article, we first explain the basic principles and technical aspects of DE-CT. Then, we wi...
Source: Journal of Medical Ultrasonics - Category: Radiology Source Type: research
Lezza Vito Pesce Nonalcoholic fatty liver disease (NAFLD) is the leading liver chronic disease featuring hepatic steatosis. Mitochondrial β-oxidation participates in the derangement of lipid metabolism at the basis of NAFLD, and mitochondrial oxidative stress contributes to the onset of the disease. We evaluated the presence and effects of mitochondrial oxidative stress in the liver from rats fed a high-fat plus fructose (HF-F) diet inducing NAFLD. Supplementation with dehydroepiandrosterone (DHEA), a multitarget antioxidant, was tested for efficacy in delaying NAFLD. A marked mitochondrial oxidative stress was ...
Source: Genes - Category: Genetics & Stem Cells Authors: Tags: Article Source Type: research
In conclusion, patients undergoing statin treatment have a lower risk of developing RVO compared to patients not taking statins.
Source: International Journal of Environmental Research and Public Health - Category: Environmental Health Authors: Tags: Article Source Type: research
To evaluate the association between statin use and the risk of developing rheumatoid arthritis (RA) in a large, US case-control study.
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Tags: Research article Source Type: research
AbstractObesity, manifested by increased adiposity, represents a main cause of morbidity in the developed countries, causing increased risk of insulin resistance and type 2 diabetes mellitus. Recruitment of macrophages and activation of innate immunity represent the initial insult, which can be further exacerbated through secretion of chemokines and adipocytokines from activated macrophages and other cells within the adipose tissue. These events can impact adipogenesis, causing dysfunction of the adipose tissue and increased risk of insulin resistance. Various factors mediate adiposity and related insulin resistance includ...
Source: Inflammation - Category: Allergy & Immunology Source Type: research
inardi Flavio Rizzolio Cancer is one of the major causes of death in developed countries and current therapies are based on surgery, chemotherapeutic agents, and radiation. To overcome side effects induced by chemo- and radiotherapy, in recent decades, targeted therapies have been proposed in second and even first lines. Targeted drugs act on the essential pathways involved in tumor induction, progression, and metastasis, basically all the hallmark of cancers. Among emerging pathways, the cholesterol metabolic pathway is a strong candidate for this purpose. Cancer cells have an accelerated metabolic rate and require ...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
Cancers, Vol. 13, Pages 4689: CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women Cancers doi: 10.3390/cancers13184689 Authors: Helena Bergström Maria Helde Frankling Caritha Klasson Anita Lövgren Sandblom Ulf Diczfalusy Linda Björkhem-Bergman More than 50% of all drugs are metabolized by the cytochrome P450 3A enzyme (CYP3A). The aim of this study was to investigate if the CYP3A activity, measured by the endogenous marker 4β-hydroxycholesterol/cholesterol ratio (4β-OHC/C), is changed during the last weeks and da...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research
More News: Cholesterol | Fatty Liver Disease (FLD) | Genetics | Insulin | Liver | Liver Disease | Neurology | Rett Syndrome | Statin Therapy | Urology & Nephrology